Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors-Reference-Cited by-同舟云学术

Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors

Published:2017-08 Issue:4 Volume:31 Page:589-612
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Patel Ami B.,O’Hare Thomas,Deininger Michael W.

Funder

V Foundation for Cancer Research

National Institutes of Health

Hope Foundation

University of Utah

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference129 articles.

1. SEER cancer statistics factsheets: chronic myeloid leukemia. Bethesda (MD): National Cancer Institute. Available at: http://seer.cancer.gov/statfacts/html/cmyl.html. Accessed November 17, 2016.

2. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia;Ren;Nat Rev Cancer,2005

3. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population;Bower;J Clin Oncol,2016

4. European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia;Steegmann;Leukemia,2016

5. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013;Baccarani;Blood,2013

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia;Pathology - Research and Practice;2024-02

2. Interplay of mutations, alternate mechanisms, and treatment breaks in leukaemia: Understanding and implications studied with stochastic models;Computers in Biology and Medicine;2024-02

3. 25 years of experience in the treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: results, opportunities, questions;Meditsinskiy sovet = Medical Council;2024-01-17

4. Exploration of treatment‐free remission in CML, based on molecular monitoring;Cancer Medicine;2023-12-22

5. Literature Review of Hematology Division The Mechanism of Imanitib Resistance in Chronic Myeloid Leukemia;Research Journal of Pharmacy and Technology;2023-11-30